Therefore, the effect of TP53 mutations on the epigenetic modification of PHLDA2/3 promoter methylation may be an important factor for their diverse functions in the occurrence and development of PAAD. The gene discussed is PHLDA2; the disease is pancreatic adenocarcinoma.